Recall archive / FDA device enforcement
Matrix Clinical Solution At-Home COVID-19 Test — FDA record Z-0947-2022
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jan 24, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Matrix Clinical Solution At-Home COVID-19 Test
- Reason
- Due to COVID-19 Test not being authorized for home sample collection.
- Classification
- Class II
- Recalling firm
- Matrix Medical Network
- Quantity
- 3,226 kits
- Agency-reported status
- Ongoing
- Source record identifier
- Z-0947-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Product Number SKU: 15206 All Test Kits No Lot Numbers |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
U.S.: AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, and WV. O.U.S.: N/A
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Apr 27, 2022
- Recall initiation date
- Jan 24, 2022
- Center classification date
- Apr 15, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.